This discovery was too important.
The discovery by the ECRC and Max Delbrück Center researchers marks a turning point in the treatment of dysferlinopathies.
Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy...
